Losing and finding a way at C: new promise for pharmacologic ascorbate in cancer treatment
- PMID: 19361554
- PMCID: PMC2981594
- DOI: 10.1016/j.freeradbiomed.2009.04.001
Losing and finding a way at C: new promise for pharmacologic ascorbate in cancer treatment
Comment on
-
Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects.Free Radic Biol Med. 2009 Jul 1;47(1):32-40. doi: 10.1016/j.freeradbiomed.2009.02.016. Epub 2009 Feb 28. Free Radic Biol Med. 2009. PMID: 19254759
References
-
- McCormick WJ. Cancer: the preconditioning factor in pathogenesis. Arch Pediatr. 1954;71:313–322. - PubMed
-
- Cameron E, Rotman D. Ascorbic acid, cell proliferation, and cancer. Lancet. 1972;1:542. - PubMed
-
- Cameron E, Campbell A, Jack T. The orthomolecular treatment of cancer. III. Reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy. Chem Biol Interact. 1975;11:387–393. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
